The path of US microbiome research

15 Feb 2016

by Kristina Campbell

With the advent of DNA sequencing and other genome-enabled technologies for studying microbial communities, countries around the world have identified microbiome research as a way to address some of their pressing problems, from food production to human health. The US government is pursuing this research in earnest, as laid out in a new report in Nature Microbiology.

Fecal microbiota transplantation (FMT) for patients with ulcerative colitis (UC) has shown mixed clinical results (see recent trials here and here). In a new pilot study, published as open access, Faming Zhang and colleagues tested the safety and efficacy of a "step-up" FMT strategy in 15 steroid-dependent UC patients.

What influences gut motility?

4 Nov 2015

by Paul Enck

Authors of a new Cell paper gave groups of germ-free mice fecal microbiota samples from six healthy adults representing five different habitual diets: American (both a standard diet and a 'primal' diet), Bangladeshi, Malawian, and Amerindian.

Researchers know the fecal microbiota of infants is a treasure trove of information -- it can reveal details about delivery mode and diet -- but microbiota-based predictions about future health are only beginning to emerge. A team of researchers led

Microbes in the gut produce a huge range of metabolites, which affect various processes in the host. Knowledge about the metabolome is limited by current experimental and computational tools, but even now, interconnections are emerging between the microbiome, the metabolome, and immunological reponses -- for instance, the possible role of metabolites in immune system pattern recognition.

A recent study of humans with celiac disease who were treated with helminths raised the possibility that an increase in microbial species richness (i.e. the number of different species present) could regulate gluten-induced inflammation in the gut.

Go to Top